α-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis

Hepatology

Volumn 33, Issue 3, 2001, Pages 676-691

  Kawai, H F ^a   Kaneko, S ^a   Honda, M ^a   Shirota, Y ^a   Kobayashi, K ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; COMPLEMENTARY DNA;

ARTICLE; CANCER CELL CULTURE; CORRELATION FUNCTION; DNA DETERMINATION; DNA MICROARRAY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOLECULAR CLONING; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0035124122     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.22500     Document Type: Article

References (53)

1. Hepatocellular carcinogenesis: Recent advances and speculations
2. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan
3. Hepatitis B viruses and cancerogenesis
4. Hepatocellular carcinoma: Recent progress
5. Hepatocellular Carcinoma
6. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
7. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma
8. Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma
9. Expression profiling using cDNA microarrays
10. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
11. Use of a cDNA microarray to analyse gene expression patterns in human cancer
12. Exploring the new world of the genome with DNA microarrays
13. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
14. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
15. In vivo gene expression profile analysis of human breast cancer progression
16. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
17. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
18. Cluster analysis and display of genome-wide expression patterns
19. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
20. Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens
21. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53
22. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines
23. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes
24. Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line
25. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression
26. Insulin suppresses hepatitis B surface antigen expression in human hepatoma cells
27. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma
28. Characterization of four new cell lines derived from human squamous carcinomas of the uterine cervix
29. Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC)
30. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation
31. Human cancer syndromes: Clues to the origin and nature of cancer
32. Data management and analysis for gene expression arrays
33. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma
34. Reactivation of the maternally imprinted IGF2 allele in TGF alpha induced hepatocellular carcinomas in mice
35. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1
36. Expression of insulin-like growth factor II (IGF-II) in human primary liver cancer: mRNA and protein analysis
37. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma
38. Establishment of a cell line from a hepatocellular carcinoma from a patient with hemochromatosis
39. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma
40. Dysregulation of apoptosis in hepatocellular carcinoma
41. Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas
42. Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models
43. Up-regulation of ephrin-A1 during melanoma progression
44. Type B monoamine oxidase activity in human brain malignant tumors
45. Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily
46. Reduction of caveolin 1 gene expression in lung carcinoma cell lines
47. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations
48. Human natural resistance-associated macrophage protein 2: Gene cloning and protein identification
49. Characterization of ephrin-A1 and ephrin-A4 as ligands for the EphA8 receptor protein tyrosine kinase
50. Ephrin-A1 is expressed at sites of vascular development in the mouse
51. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
52. p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis
53. Detection of neutral endopeptidase 24.11 (neprilysin) in human hepatocellular carcinomas by immunocytochemistry